General Information of Drug Transporter (DT)
DT ID DTD0224 Transporter Info
Gene Name SLC25A7
Transporter Name Mitochondrial brown fat uncoupling protein 1
Gene ID
7350
UniProt ID
P25874
Post-Translational Modification of This DT
Overview of SLC25A7 Modification Sites with Functional and Structural Information
Sequence
PTM type
X-Phosphorylation X-Ubiquitination X: Amino Acid

Phosphorylation

  Serine

          4 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC25A7 [1]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

88

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC25A7 Serine 88 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence SLC25A7 [1]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

90

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC25A7 Serine 90 has the potential to affect its expression or activity.

  PTM Phenomenon 3

Have the potential to influence SLC25A7 [2]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

145

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC25A7 Serine 145 has the potential to affect its expression or activity.

  PTM Phenomenon 4

Have the potential to influence SLC25A7 [3] , [4]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

250

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC25A7 Serine 250 has the potential to affect its expression or activity.

  Threonine

          8 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC25A7 [5]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

104

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC25A7 Threonine 104 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence SLC25A7 [6]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

155

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC25A7 Threonine 155 has the potential to affect its expression or activity.

  PTM Phenomenon 3

Have the potential to influence SLC25A7 [6]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

157

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC25A7 Threonine 157 has the potential to affect its expression or activity.

  PTM Phenomenon 4

Have the potential to influence SLC25A7 [6]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

166

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC25A7 Threonine 166 has the potential to affect its expression or activity.

  PTM Phenomenon 5

Have the potential to influence SLC25A7 [6]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

167

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC25A7 Threonine 167 has the potential to affect its expression or activity.

  PTM Phenomenon 6

Have the potential to influence SLC25A7 [6]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

171

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC25A7 Threonine 171 has the potential to affect its expression or activity.

  PTM Phenomenon 7

Have the potential to influence SLC25A7 [3] , [4]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

260

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC25A7 Threonine 260 has the potential to affect its expression or activity.

  PTM Phenomenon 8

Have the potential to influence SLC25A7 [3] , [4]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

265

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC25A7 Threonine 265 has the potential to affect its expression or activity.

  Tyrosine

          5 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC25A7 [3] , [7]

Role of PTM

Potential impacts

Modified Residue

Tyrosine

Modified Location

55

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC25A7 Tyrosine 55 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence SLC25A7 [6]

Role of PTM

Potential impacts

Modified Residue

Tyrosine

Modified Location

154

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC25A7 Tyrosine 154 has the potential to affect its expression or activity.

  PTM Phenomenon 3

Have the potential to influence SLC25A7 [6]

Role of PTM

Potential impacts

Modified Residue

Tyrosine

Modified Location

158

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC25A7 Tyrosine 158 has the potential to affect its expression or activity.

  PTM Phenomenon 4

Have the potential to influence SLC25A7 [6]

Role of PTM

Potential impacts

Modified Residue

Tyrosine

Modified Location

161

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC25A7 Tyrosine 161 has the potential to affect its expression or activity.

  PTM Phenomenon 5

Have the potential to influence SLC25A7 [8]

Role of PTM

Potential impacts

Modified Residue

Tyrosine

Modified Location

248

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC25A7 Tyrosine 248 has the potential to affect its expression or activity.

Ubiquitination

  Unclear Residue

          1 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

May accelerating UCP1 degradation [9]

Role of PTM

Degradation via Proteosome

Experimental Method

Co-Immunoprecipitation

Detailed Description

Ubiquitination at UCP1 have been reported to potentially accelerate its degradation, thereby affecting its expression or activity.
References
1 Global phosphoproteomics of activated B cells using complementary metal ion functionalized soluble nanopolymers. Anal Chem. 2014 Jul 1;86(13):6363-71.
2 In situ sample processing approach (iSPA) for comprehensive quantitative phosphoproteome analysis. J Proteome Res. 2014 Sep 5;13(9):3896-904.
3 Systematic functional prioritization of protein posttranslational modifications. Cell. 2012 Jul 20;150(2):413-25.
4 Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions. Sci Signal. 2009 Aug 18;2(84):ra46.
5 Phosphoprotein secretome of tumor cells as a source of candidates for breast cancer biomarkers in plasma. Mol Cell Proteomics. 2014 Apr;13(4):1034-49.
6 Citric acid-assisted two-step enrichment with TiO2 enhances the separation of multi- and monophosphorylated peptides and increases phosphoprotein profiling. J Proteome Res. 2013 Jun 7;12(6):2467-76.
7 Global survey of phosphotyrosine signaling identifies oncogenic kinases in lung cancer. Cell. 2007 Dec 14;131(6):1190-203.
8 Ultra-deep tyrosine phosphoproteomics enabled by a phosphotyrosine superbinder. Nat Chem Biol. 2016 Nov;12(11):959-966.
9 UniProt: the Universal Protein Knowledgebase in 2023. Nucleic Acids Res. 2023 Jan 6;51(D1):D523-D531. (ID: P25874)

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.